The Relationships Between the Cardiovascular Effects, α- and β-Adrenoceptor Blocking Actions and Plasma Concentration of Labetalol in Doca Hypertensive Rats
- 1 January 1979
- journal article
- research article
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 1 (5) , 597-611
- https://doi.org/10.3109/10641967909068627
Abstract
The relationships between the cardiovascular effects, α- and β-adrenoceptor blocking actions and plasma concentration of labetalol have been examined in conscious DOCA hypertensive rats. Labetalol (10, 30 and 100mg/kg p.o.) reduced resting heart rate; blood pressure was reduced only by the two higher doses. The effects lasted 5-24 hours. There was a highly significant correlation between the plasma labetalol concentration and its cardiovascular effects. During the labetalol-induced hypotension and bradycardia the vasopressor responses to intra-arterial injections of phenylephrine were reduced; the tachycardia and vasodepressor responses produced by intra-arterial injections of isoprenaline were also reduced. It is concluded that α-and β-adrenoceptor blockade probably account for the labetalol-induced decreases in resting blood pressure and heart rate respectively.This publication has 9 references indexed in Scilit:
- Studies on the mechanism of the vasodilator effects of prazosin in dogs and rabbitsEuropean Journal of Pharmacology, 1978
- PrazosinDrugs, 1977
- A Non-Parametric Equivalent of Williams' Test for Contrasting Increasing Dose Levels of a TreatmentPublished by JSTOR ,1977
- Relationship between plasma concentrations and pharmacological effects of labetalolEuropean Journal of Clinical Pharmacology, 1977
- Assessment of alpha‐ and beta‐adrenoceptor blocking actions of labetalol.British Journal of Clinical Pharmacology, 1976
- Permanent cannulation of aorta and vena cava in rats and ground squirrelsJournal of Applied Physiology, 1960
- THE BIOLOGY OF METACORTICOID HYPERTENSIONAnnals of Internal Medicine, 1958
- GANGLIONIC BLOCKADE BY A NEW BISQUATERNARY SERIES, INCLUDING CHLORISONDAMINE DIMETHOCHLORIDE1955